Before you sell to, join or invest in Immorta Bio, Inc.
MentionFox check on Immorta Bio, Inc.: only 1 source on file so far (checked 8 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/immorta-bio-inc-form-d-26000001
Check Immorta Bio, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
Immorta Bio, Inc. filed a Form D with the Securities and Exchange Commission on 2026-01-08.
Immorta Bio, Inc. filed a Form D notice of an exempt securities offering with the SEC on January 8, 2026. The filing reports $450K sold. Its industry group is Biotechnology. It names Boris Reznik (Executive Officer) (SEC Form D, January 8, 2026).
In its own words: “Immorta Bio is a longevity biotech company developing stem-cell and senescent-cell therapeutics to reverse biological aging and unlock regenerative healthspan.” (immortabio.com, checked November 1, 2026)
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like Immorta Bio, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-01-08 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Immorta Bio, Inc.
Free to see. No signup.
More on the people and the money behind Immorta Bio, Inc., from the filings we hold.
Biotechnology raises by companies based in Florida, filed within 90 days of this one, largest first.
Get an email when Immorta Bio, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Immorta Bio, Inc. raises, hires or launches. No email unless you switch it on.
Watch Immorta Bio, Inc. →Get the full cited report on Immorta Bio, Inc.
What the filing shows about Immorta Bio, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Immorta Bio, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Immorta Bio, Inc.'s address as 7064 Fisher Island Drive, Miami Beach, FL 33109.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Immorta Bio, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Immorta Bio, Inc. is a registered filer with the SEC (CIK 2102665) and has filed since 2026-01-08. 2 filings are on record, the latest on 2026-10-16.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Immorta Bio, Inc.'s Form D of 2026-01-08 names Boris Reznik as its officers, directors or promoters.
Its new offerings report $1.06M sold across 2 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 763 filings in Biotechnology, totalled by week. The dot is this raise, $450K, on the same scale — one filing against the whole group's total, so it sits low by construction.
Boris Reznik is named as Executive Officer on the Form D that Immorta Bio, Inc. filed with the SEC on 8 January 2026, the only person that filing names.
1 person named on the filing — 1 holding an executive role.
Named as of the 2026-01-08 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
What the filing shows about Immorta Bio, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Immorta Bio, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Immorta Bio, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Immorta Bio, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Immorta Bio, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Immorta Bio, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in Miami
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/immorta-bio-inc-form-d-26000001